SUBSCRIBE
SUBSCRIBE
News   Policy

Cornerstone Therapeutics Inc. Gets U.S. FDA Warning

November 23, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators warned Cornerstone Therapeutics that the company has distributed drugs without approved applications, a letter released on Friday said.
Regulatory
Food and Drug Administration (FDA) Chiesi, USA
MORE ON THIS TOPIC
Yellow warning sign symbol or alert safety danger caution illustration icon security message and exclamation triangle information icon on attention traffic background with secure alarm. 3D render.
Regulatory
Hims & Hers’ Woes Compound as FDA Hits Company With Warning Letter
February 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.
Complete response letters
REGENXBIO’s Hunter Syndrome Gene Therapy Fails To Win FDA Nod
February 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Red round circle with a pause button or icon against yellow background.
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
February 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Magnifying glass focusing on number 2026 with target icon on yellow background. Concept for new year focus, business goals, trends, planning, strategy, vision, success, and future opportunities.
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
February 9, 2026
 · 
6 min read
 · 
Claire Davies